Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002471]
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002471]
Bio2RDF identifier
NCT00002471
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00002471
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... rrent non-Hodgkin's lymphoma.
brief title [clinicaltrials_vocabulary:brief-title]
Combination Chemotherapy in Tr ...... emia or Non-Hodgkin's Lymphoma
completion date [clinicaltrials_vocabulary:completion-date]
2003-01-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Improve ...... m the start of
therapy.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
B-cell adult acute lymphoblastic leukemia
B-cell childhood acute lymphoblastic leukemia
L3 adult acute lymphoblastic leukemia
L3 childhood acute lymphoblastic leukemia
childhood Burkitt lymphoma
recurrent adult Burkitt lymphoma
recurrent adult diffuse large cell lymphoma
recurrent adult immunoblastic large cell lymphoma
recurrent adult non-Hodgkin lymphoma
recurrent childhood large cell lymphoma
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-06-19T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00002471
official title [clinicaltrials_vocabulary:official-title]
Phase II Trial of Intensive, S ...... current Non-Hodgkin's Lymphoma
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2003-01-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
CDR0000076672
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1990-02-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-06-01T00:00:00Z
identifier
clinicaltrials:NCT00002471
title
Combination Chemotherapy in Tr ...... emia or Non-Hodgkin's Lymphoma
@en
type
label
Combination Chemotherapy in Tr ...... a [clinicaltrials:NCT00002471]
@en